Research pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States

Journal of the American Pharmacists Association

Volumn 49, Issue 1, 2009, Pages 43-50

  Landau, Sharon ^a   Besinque, Kathleen ^b   Chung, Frances ^c   Dries Daffner, Ingrid ^d   Maderas, Nicole Monastersky ^a   McGhee, Belle Taylor ^e   Foster, Diana Greene ^f  

^a Pharmacy Access Partnership   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d Berkeley Media Studies Group   (United States)

^e Pacific Institute for Women's Health   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contraceptives; Pharmacy access drug products; Surveys

Indexed keywords

CONTRACEPTIVE AGENT;

ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; MALE; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PSYCHOLOGICAL ASPECT; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVE AGENTS, FEMALE; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; PHARMACEUTICAL SERVICES; PHARMACISTS; UNITED STATES;

EID: 63849234698     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.07154     Document Type: Article

References (14)

1. Jones EF, Forrest JD, Henshaw SK, et al. Unintended pregnancy, contraceptive practice and family planning services in developed countries. Fam Plann Perspect. 1988;20:53-5, 58-67.
2. Leeman L. Medical barriers to effective contraception. Obstet Gynecol Clin North Am. 2007;34:19-29.
3. Harper C, Balistreri E, Boggess J, et al. Provision of hormonal contraceptives without a mandatory pelvic examination: the First Stop demonstration project. Fam Plann Perspect. 2001;33:13-8.
4. Potts M, Denny C. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status. Drug Saf. 1995;13:333-7.
5. Scott A, Glasier AF. Are routine breast and pelvic examinations necessary for women starting combined oral contraception? Hum Reprod Update. 2004;10:449-52.
6. Stewart FH, Harper CC, Ellertson CE, et al. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. JAMA. 2001;285:2232-9.
7. World Health Organization. Improving access to quality care in family planning: medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva: World Health Organization; 1996.
8. American College of Obstetricians and Gynecologists. ACOG practice bulletin: cervical cytology screening: number 45, August 2003. Int J Gynaecol Obstet. Nov 2003;83:237-47.
9. U.S. Food and Drug Administration. Labeling guidance text for combination oral contraceptives, prescribing information, physician labeling; 1994. Accessed at www.fda.gov/ohrms/dockets/dailys/04/may04/050604/050604.htm, July 14, 2006.
10. Pharmacy Access Partnership. Pharmacy policy & legislation. Accessed at www.go2ec.org/Legislation.htm, October 25, 2007.
11. IMS. National Prescription Audit: 2002-2007.
12. American Pharmacists Association. Pharmacists' authority to initiate, adjust, and/or administer hormonal contraception therapy as of January 15, 2005. Washington, DC: American Pharmacists Association; 2005.
13. Landau SC, Parker MT, Taylor-McGhee B. Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception. 2006;74:463-70.
14. Foster DG, Landau SC, Monastersky N, et al. Pharmacy access to emergency contraception in California. Perspect Sex Reprod Health. 2006;38:46-52.